CRISPR — the revolutionary gene-editing technology discovered 13 years ago at UC Berkeley — is saving lives. Just ask Victoria Gray, whose sickle cell disease was cured five years ago by a CRISPR gene therapy. She’s now pain free, and her success has paved the way for dozens of other patients. Or look to the case of an infant born last year with a life-threatening genetic disease that prevented him from breaking down the proteins in his food. After being diagnosed, Berkeley researchers worked with his physicians to prove the safety of a custom CRISPR therapy for his disease — all in less than seven months, an unprecedented time frame for a personalized therapeutic. These life-saving treatments would not have happened without funding from the National Science Foundation for the research that led to CRISPR. To date, the technology has been used not only to cure genetic diseases, but also to treat cancer and heart disease. At the Innovative Genomics Institute, researchers are stream...